Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2012
09/20/2012US20120237946 Mesenchymal stem cell and the method of use thereof
09/20/2012US20120237625 Metabolism accelerating composition comprising astragali radix extract
09/20/2012US20120237617 Use of nitrite salts in treating tissue damage
09/20/2012US20120237603 Abuse-resistant opioid dosage form
09/20/2012US20120237602 Press-coated orally-disintegrating tablets
09/20/2012US20120237599 Enterically coated cysteamine, cystamine and derivatives thereof
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237587 Combination preparation including a corticosteroid and exosomes
09/20/2012US20120237570 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237563 Controlled-release formulations of anabaseine compounds and uses thereof
09/20/2012US20120237561 injectable formulations containing asenapine and method of treatment using same
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012US20120237529 Diagnostic antibody assay
09/20/2012US20120237526 Bace1 inhibitory antibodies
09/20/2012US20120237521 Compositions and methods for increasing muscle growth
09/20/2012US20120237508 Fused amino pyridine as hsp90 inhibitors
09/20/2012US20120237505 Targeting of cd8+ t-lymphocytes to treat neurodegenerative diseases
09/20/2012US20120237504 Compositions and methods for treating inflammation and fibrosis
09/20/2012US20120237496 Protease variants
09/20/2012US20120237487 Mesenchymal stem cell and the method of use thereof
09/20/2012US20120237486 Mesenchymal stem cell and the method of use thereof
09/20/2012US20120237484 Generation of Functional Basal Forebrain Cholinergic Neurons From Stem Cells
09/20/2012US20120237482 Methods for treatment of neurological disorders by modulation of microglial activation
09/20/2012US20120237479 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237461 Skin compositions and methods of use thereof
09/20/2012US20120237449 Methods for treating neural cell swelling
09/20/2012US20120237448 Sphingosine kinase type 1 inhibitors, and processes for using same
09/20/2012US20120237446 Compounds for binding and imaging amyloid plaques and their use
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012US20120234721 Diuretic and diuretic-like compound analogs
09/20/2012DE102011015142A1 Agens zur Prophylaxe und Behandlung altersassoziierter Krankheiten und Störungen sowie zur Verlängerung der Lebensdauer Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as extending the life
09/20/2012CA2846786A1 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830043A1 Novel phenylpyridine derivative and drug containing same
09/20/2012CA2829223A1 Method for treating neurodegenerative tauopathy
09/20/2012CA2827629A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/20/2012CA2827275A1 Copolymer-1, process for preparation and analytical methods thereof
09/19/2012EP2500361A1 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
09/19/2012EP2500344A1 Aminothiazine or aminooxazine derivative having amino linker
09/19/2012EP2500337A2 Solid form comprising (-) o-desmethylvenlafaxine and uses thereof
09/19/2012EP2500027A1 Composition for counteracting smoking toxicity
09/19/2012EP2500018A1 Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
09/19/2012EP2500017A1 Use of ketogenic compounds for treatment of age-associated memory impairment
09/19/2012EP2500016A1 Doxylamine resinate complex
09/19/2012EP2499148A2 Conformationally constrained, fully synthetic macrocyclic compounds
09/19/2012EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499129A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012EP2499121A1 Oxazoline derivatives for treatment of cns disorders.
09/19/2012EP2498786A1 Xenon-based inhalable drug for treating or preventing induced dyskinesia
09/19/2012EP1666481B1 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
09/19/2012CN202437630U Chinese herbal medicine channel-following massage stick
09/19/2012CN1872066B Extract from roots, halms, leaves of croton, effective content of anti inflammation and analgesia, and uses thereof
09/19/2012CN102686596A Azabicyclo[2.2.1] heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
09/19/2012CN102686595A Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
09/19/2012CN102686590A Pyrazoline dione derivatives as NADPH oxidase inhibitors
09/19/2012CN102686589A Ethynyl derivatives
09/19/2012CN102686586A Histamine H3 inverse agonists and antagonists and methods of use thereof
09/19/2012CN102686584A Aminothiazine or aminooxazine derivative having amino linker
09/19/2012CN102686580A Imidazole derivative as casein kinase inhibitors
09/19/2012CN102686575A Modulators of G protein-coupled receptor 88
09/19/2012CN102686572A Oxazoline derivatives for treatment of CNS disorders
09/19/2012CN102686569A Phenoxy-substituted pyrimidines as opioid receptor modulators
09/19/2012CN102686564A 吡咯烷衍生物 Pyrrolidine derivative
09/19/2012CN102686234A Composition for improving brain function and method for improving brain function
09/19/2012CN102676396A Paecilomyces tenuipes strain and application thereof
09/19/2012CN102675453A Adrenocorticotrophic hormone (ACTH) analogue, preparation method and application thereof
09/19/2012CN102675419A Abeta oligopeptide polymerization inhibitor and preparation and application thereof
09/19/2012CN102675380A Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate
09/19/2012CN102675341A Dihydro-triazole and benzo two nitrogen heterocyclic ketones compound, processes for their preparation and pharmaceutical compositions comprising these compounds
09/19/2012CN102675315A Substitutive benzene alkyl contained purine compounds and preparation method and application thereof
09/19/2012CN102675300A Lipoic acid-aporphine conjugated compound, medicine composite and usage thereof
09/19/2012CN102675299A Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate
09/19/2012CN102675286A Indazoles compound, and preparation method and application thereof, and medical composition
09/19/2012CN102675244A Thiazine amide derivative and application thereof in preparation of medicines for preventing and controlling neurodegenerative diseases
09/19/2012CN102675228A Medicine for treating ischemic brain injury stroke and sequela of ischemic brain injury stroke and preparation method for medicine
09/19/2012CN102675206A Preparation method of novel acetylcholinesterase inhibitor, and activity thereof
09/19/2012CN102675134A Nitrogen-containing substituent curcumin analogue and medical application thereof
09/19/2012CN102675114A Curcumin-containing acetylsalicylate derivative, preparation method and application thereof
09/19/2012CN102671230A Traditional Chinese medicine incense for refreshing
09/19/2012CN102671195A Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid
09/19/2012CN102671185A Application of scolopendra mutilans neurotoxin peptide omega-SLPTX-Ssmla
09/19/2012CN102671139A Medicament for treating depressive neurosis
09/19/2012CN102671115A Traditional Chinese medicine composition for treating headache and preparation method thereof
09/19/2012CN102671066A Hangover-alleviating compound and preparation method thereof
09/19/2012CN102671053A Medicament for treating autism and preparation method thereof
09/19/2012CN102671033A Traditional Chinese medicine composition for improving sleep and strengthening organism immunity, and clinical preparation thereof
09/19/2012CN102671008A Compound fangji root infusion
09/19/2012CN102671007A Medicament for treating senile dementia and preparation method thereof
09/19/2012CN102671004A Traditional Chinese medicine oral liquid for relieving epilepsy and preparation method thereof
09/19/2012CN102670999A Prescription of dendrobium nobile pills and processing process thereof
09/19/2012CN102670998A Traditional Chinese medicine for treating facial paralysis
09/19/2012CN102670952A Medicine for treating insomnia
09/19/2012CN102670920A Good-health traditional Chinese medicine preparation with improved stability
09/19/2012CN102670882A Chinese medicinal preparation for treating facial paralysis through oral administration
09/19/2012CN102670880A Chinese medicine for treating diabetic peripheral neuropathy
09/19/2012CN102670876A Chinese medicine for treating diabetic peripheral neuropathy
09/19/2012CN102670755A Medicated wine for treating hemiplegia and production method thereof
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 1833